Publications by authors named "Nestor Jonguitud-Borrego"

In the quest for innovative cancer therapeutics, paclitaxel remains a cornerstone in clinical oncology. However, its complex biosynthetic pathway, particularly the intricate oxygenation steps, has remained a puzzle in the decades following the characterization of the last taxane hydroxylase. The high divergence and promiscuity of enzymes involved have posed significant challenges.

View Article and Find Full Text PDF

Background: Integrated metabolic engineering approaches that combine system and synthetic biology tools enable the efficient design of microbial cell factories for synthesizing high-value products. In this study, we utilized in silico design algorithms on the yeast genome-scale model to predict genomic modifications that could enhance the production of early-step Taxol in engineered Saccharomyces cerevisiae cells.

Results: Using constraint-based reconstruction and analysis (COBRA) methods, we narrowed down the solution set of genomic modification candidates.

View Article and Find Full Text PDF

In situ product recovery is an efficient way to intensify bioprocesses as it can perform adsorption of the desired natural products in the cultivation. However, it is common to use only one adsorbent (liquid or solid) to perform the product recovery. For this study, the use of an in situ product recovery method with three combined commercial resins (HP-20, XAD7HP, and HP-2MG) with different chemical properties was performed.

View Article and Find Full Text PDF

Thanks to its sophistication, the CRISPR/Cas system has been a widely used yeast genome editing method. However, CRISPR methods generally rely on preassembled DNAs and extra cloning steps to deliver gRNA, Cas protein, and donor DNA. These laborious steps might hinder its usefulness.

View Article and Find Full Text PDF
Article Synopsis
  • The COVID-19 pandemic has created immense pressure on global healthcare systems, with over 6 million deaths and 530 million confirmed cases, highlighting the need for effective testing and tracking.
  • To meet rising testing demands, automated workflows have emerged as a solution, enhancing efficiency and accuracy in diagnostic processes through high-throughput screening and reduced human error.
  • While RT-qPCR remains the gold standard for COVID-19 testing, various new methods are being developed, and case studies from countries like China, Spain, and the UK show automation's effectiveness, though challenges like the implementation of Free and Open Source hardware persist.
View Article and Find Full Text PDF

The COVID-19 pandemic has had an enormous impact on economies and health systems globally, therefore a top priority is the development of increasingly better diagnostic and surveillance alternatives to slow down the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In order to establish massive testing and contact tracing policies, it is crucial to have a clear view of the diagnostic options available and their principal advantages and drawbacks. Although classical molecular methods such as RT-qPCR are broadly used, diagnostic alternatives based on technologies such as LAMP, antigen, serological testing, or the application of novel technologies such as CRISPR-Cas for diagnostics, are also discussed.

View Article and Find Full Text PDF

Background: Cost-effective production of the highly effective anti-cancer drug, paclitaxel (Taxol), remains limited despite growing global demands. Low yields of the critical taxadiene precursor remains a key bottleneck in microbial production. In this study, the key challenge of poor taxadiene synthase (TASY) solubility in S.

View Article and Find Full Text PDF